Carregant...

Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action

Our study demonstrates that Pt(iv) derivative of cisplatin, with two axial PhB ligands, ctc-[Pt(NH(3))(2)(PhB)(2)Cl(2)], is a very potent cytotoxic agent against many different human cancer cell lines and is up to 100 fold more potent than cisplatin, and significantly more potent than the Pt(iv) der...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chem Sci
Autors principals: Raveendran, Raji, Braude, Jeremy Phillip, Wexselblatt, Ezequiel, Novohradsky, Vojtech, Stuchlikova, Olga, Brabec, Viktor, Gandin, Valentina, Gibson, Dan
Format: Artigo
Idioma:Inglês
Publicat: Royal Society of Chemistry 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6003606/
https://ncbi.nlm.nih.gov/pubmed/29997781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c5sc04205d
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!